Literature DB >> 19335370

Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.

R Leclercq1.   

Abstract

The spread of methicillin-resistant Staphylococcus aureus is continuous. The emergence of community-acquired methicillin-resistant S. aureus (CA-MRSA) was rapidly followed by its introduction into and dissemination in hospitals in countries where CA-MRSA prevalence is high. Vancomycin-resistant enterococci have recently been responsible for outbreaks in European hospitals in relation to dissemination of hospital-adapted isolates. Although new antimicrobials have been recently introduced into therapy to fight multidrug-resistant Gram-positive cocci, resistance to these compounds has already emerged in rare strains. This review presents recent data concerning the advance of our knowledge related to these problems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335370     DOI: 10.1111/j.1469-0691.2009.02739.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  30 in total

1.  [Epidemiology of and preventive measures for multiresistant pathogens].

Authors:  E-B Kruse; M Dettenkofer
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

2.  Multidrug-resistant enterococci in animal meat and faeces and co-transfer of resistance from an Enterococcus durans to a human Enterococcus faecium.

Authors:  Carla Vignaroli; Giada Zandri; Lucia Aquilanti; Sonia Pasquaroli; Francesca Biavasco
Journal:  Curr Microbiol       Date:  2011-02-01       Impact factor: 2.188

Review 3.  Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends.

Authors:  Erwin A Kruger; Marilyn Pires; Yvette Ngann; Michelle Sterling; Salah Rubayi
Journal:  J Spinal Cord Med       Date:  2013-05-21       Impact factor: 1.985

4.  Antimicrobial Susceptibility and Enterotoxin-Encoding Genes in Staphylococcus spp. Recovered from Kitchen Equipment from a University Hospital in Rio de Janeiro, Brazil.

Authors:  Roberta Fontanive Miyahira; Emanoella Araújo Santos; Robson Souza Leão; Angela Corrêa de Freitas-Almeida; Mara Lucia Queiroz
Journal:  Microb Drug Resist       Date:  2018-03-20       Impact factor: 3.431

Review 5.  Public Health Risks of Multiple-Drug-Resistant Enterococcus spp. in Southeast Asia.

Authors:  Diane Sunira Daniel; Sui Mae Lee; Gary A Dykes; Sadequr Rahman
Journal:  Appl Environ Microbiol       Date:  2015-07-06       Impact factor: 4.792

6.  Impact of a short period of pre-enrichment on detection and bacterial loads of methicillin-resistant Staphylococcus aureus from screening specimens.

Authors:  L Van Heirstraeten; J Cortiñas Abrahantes; C Lammens; A Lee; S Harbarth; G Molenberghs; M Aerts; H Goossens; S Malhotra-Kumar
Journal:  J Clin Microbiol       Date:  2009-08-12       Impact factor: 5.948

7.  Prevalence of and risk factors for biliary carriage of bacteria showing worrisome and unexpected resistance traits.

Authors:  E Maseda; G Maggi; R Gomez-Gil; G Ruiz; R Madero; A Garcia-Perea; L Aguilar; F Gilsanz; J Rodriguez-Baño
Journal:  J Clin Microbiol       Date:  2012-11-28       Impact factor: 5.948

8.  Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers.

Authors:  A Sotto; J-L Richard; C Combescure; N Jourdan; S Schuldiner; N Bouziges; J-P Lavigne
Journal:  Diabetologia       Date:  2010-06-23       Impact factor: 10.122

9.  Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources.

Authors:  René Augustin; Friederike Anton-Erxleben; Stephanie Jungnickel; Georg Hemmrich; Björn Spudy; Rainer Podschun; Thomas C G Bosch
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

10.  Artificial opsonin enhances bacterial phagocytosis, oxidative burst and chemokine production by human neutrophils.

Authors:  Kristy N Katzenmeyer; Luisa M Szott; James D Bryers
Journal:  Pathog Dis       Date:  2017-08-31       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.